关于公司与重整投资人签署《重整投资协议》的公告

Overview - The company, Chongqing Huicheng Information Technology Co., Ltd. (referred to as "Huicheng Technology"), is undergoing a pre-restructuring process initiated by its creditor, Chongqing Lvfa Asset Management Co., Ltd., due to its inability to repay debts and lack of repayment capacity, despite having restructuring value [1][2] Restructuring Process - On August 9, 2025, the company announced the public recruitment of restructuring investors to mitigate debt risks and improve operational capabilities, with a deadline for submissions set for August 24, 2025 [2] - By August 28, 2025, three potential investors had submitted their applications and paid the required deposit [2] - On September 2, 2025, the company selected Zhi'en Biotechnology Co., Ltd. as the restructuring investor after evaluating the submitted restructuring investment plans [3] Investment Agreement - The company signed a restructuring investment agreement with Zhi'en Biotechnology, which aims to restore profitability, reduce debt burdens, and maintain its listing status [4][10] - Zhi'en Biotechnology will provide financial support and become the controlling shareholder post-restructuring, enhancing the company's core competitiveness [10][20] Investor Profile - Zhi'en Biotechnology, established on April 2, 2001, has a registered capital of 93.526 million yuan and operates in the pharmaceutical sector, focusing on drug research, production, and sales [5][6][7] - The actual controller of Zhi'en Biotechnology is Mr. Huang Shan, who holds a 62.78% stake through affiliated companies [6][7] Financial Data - Zhi'en Biotechnology is recognized as a national high-tech enterprise and has received various national qualifications, indicating its strong position in the pharmaceutical industry [7][8] Share Structure and Control Changes - The restructuring plan includes a capital increase through stock conversion, with Zhi'en Biotechnology set to acquire 232 million shares, representing approximately 20.04% of the company post-restructuring [12][50] - The total share capital will increase from 784.16 million to 1.16 billion shares, with the restructuring investor potentially changing the company's control dynamics [50][51] Impact on the Company - The signing of the restructuring investment agreement is a critical step in the pre-restructuring and restructuring process, aimed at optimizing the company's asset-liability structure and mitigating debt risks [51] - Successful restructuring is expected to enhance the company's operational and profitability capabilities, facilitating a return to sustainable development [51]